Back to Search Start Over

TCR Dependent Metabolic Programming Regulates Autocrine IL-4 Production Resulting in Self-Tuning of the CD8 + T Cell Activation Setpoint.

Authors :
Crofts KF
Holbrook BC
Soto-Pantoja DR
Ornelles DA
Alexander-Miller MA
Source :
Frontiers in immunology [Front Immunol] 2020 Mar 31; Vol. 11, pp. 540. Date of Electronic Publication: 2020 Mar 31 (Print Publication: 2020).
Publication Year :
2020

Abstract

The ability of T cells to sense and respond to environmental cues by altering their functional capabilities is critical for a safe and optimally protective immune response. One of the important properties that contributes to this goal is the activation set-point of the T cell. Here we report a new pathway through which TCR transgenic OT-I CD8 <superscript>+</superscript> T cells can self-tune their activation threshold. We find that in the presence of a strong TCR engagement event there is a shift in the metabolic programming of the cell where both glycolysis and oxidative phosphorylation are significantly increased. This diverges from the switch to a predominantly glycolytic profile that would be predicted following naïve T cell activation. Our data suggest this altered metabolic program results in the production of autocrine IL-4. Both metabolic pathways are required for this cytokine to be made. IL-4 signaling in the activated OT-I CD8 <superscript>+</superscript> T cell results in modulation of the sensitivity of the cell, establishing a higher activation setpoint that is maintained over time. Together these data demonstrate a novel mechanism for the regulation of IL-4 production in CD8 <superscript>+</superscript> T cells. Further, they reveal a new pathway for the self-tuning of peptide sensitivity. Finally, these studies uncover an unexpected role for oxidative phosphorylation in regulating differentiation in these cells.<br /> (Copyright © 2020 Crofts, Holbrook, Soto-Pantoja, Ornelles and Alexander-Miller.)

Details

Language :
English
ISSN :
1664-3224
Volume :
11
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Academic Journal
Accession number :
32300344
Full Text :
https://doi.org/10.3389/fimmu.2020.00540